Wednesday, July 15, 2026 brings one of the heaviest earnings days of the Q2 2026 reporting season. Companies spanning semiconductors, healthcare, financial services, insurance, energy, transportation, and airlines are all set to report results.
The reports arrive as the S&P 500 trades near record levels following a strong first half of 2026, with investors focused on whether corporate earnings can sustain the broader market rally. Several of today's reporters carry significant weight for their respective sectors — and for the market as a whole.
ASML is the world's sole supplier of extreme ultraviolet (EUV) lithography machines — the specialized equipment chipmakers such as TSMC, Samsung, and Intel require to manufacture the world's most advanced semiconductors. The company holds a monopoly over EUV technology, making it a critical link in the global chip supply chain.
Analysts forecast Q2 2026 EPS of approximately $7.98 per share, which would represent a roughly 75% increase from the year-ago quarter, according to Zacks Investment Research. Revenue consensus sits around $10.28 billion, reflecting an approximate 18% increase year-over-year. ASML's own Q2 guidance called for net sales between €8.4 billion and €9.0 billion, with a gross margin of 51–52%.
Investors are paying particular attention to ASML's EUV order backlog and management's commentary on 2026 and 2027 chip equipment demand, with AI-driven semiconductor investment providing a powerful tailwind. ASML raised its full-year 2026 revenue guidance to €36–40 billion following Q1 results.
Notably, ASML eliminated its disclosure of quarterly net bookings starting this year — a change that shifts market focus to management's qualitative commentary on forward demand. Analyst price targets range widely, with Bernstein at $2,623 on the bullish end, reflecting AI-driven EUV demand expectations.
Johnson & Johnson is one of the world's largest healthcare companies, operating two primary segments: Innovative Medicine (pharmaceuticals) and MedTech (medical devices and diagnostics). The company generated over $88 billion in revenue in fiscal year 2024.
Analysts expect Q2 2026 EPS of approximately $2.86 per share on revenue of roughly $25 billion. Investors will focus on the Innovative Medicine pipeline, particularly oncology franchise growth and any biosimilar competition impacts, as well as the MedTech segment's momentum in robotic-assisted surgery and electrophysiology.
J&J has maintained a pattern of beating quarterly estimates and raising full-year guidance in recent years, reinforcing its reputation as a steady defensive healthcare holding.
Morgan Stanley is one of the largest global investment banks and wealth management firms, with total client assets approaching management's $10 trillion long-term target. The firm earns revenue across institutional securities (trading and investment banking), wealth management, and investment management.
The consensus Q2 2026 EPS estimate is approximately $2.93 per share on revenue of roughly $19.6 billion. Investors are watching investment banking fee activity and M&A advisory revenue, given the broadly improving deal-making environment in 2026. Wealth management revenue growth will also be a key focus.
Morgan Stanley is the last of the largest U.S. banks to report this week, following JPMorgan Chase, Goldman Sachs, Citigroup, Wells Fargo, and Bank of America, most of which beat estimates on strong trading and investment banking activity.
BlackRock is the world's largest asset manager, with total assets under management (AUM) that surpassed $11.6 trillion as of Q1 2026. The company's iShares platform is the global leader in exchange-traded funds, and BlackRock's results serve as a bellwether for institutional investment flows worldwide.
Analysts estimate Q2 2026 EPS of approximately $12.57 per share on revenue of roughly $6.7 billion. Focus will be on net new assets, iShares ETF inflows, institutional trends, and commentary on the growing alternatives and private markets business, where BlackRock has made significant acquisitions.
Progressive is the third-largest auto insurance company in the United States. The company's data-driven underwriting model and aggressive digital marketing have fueled consistent premium growth in recent years.
Analyst consensus for Q2 2026 stands at approximately $4.73 per share in EPS. Investors will track Progressive's combined ratio — the key insurance profitability metric — along with net premium written growth and claims trends. Progressive reports monthly premium data, providing investors real-time visibility into performance.
Bank of New York Mellon is the world's largest custodian bank, responsible for safeguarding approximately $54 trillion in assets for institutional clients globally. The bank earns most of its revenue through asset servicing and wealth management fees rather than traditional lending.
Analysts project Q2 2026 EPS of approximately $2.22 per share. Fee revenue trends, custody asset flows, and commentary on interest rate sensitivity will be the primary focus areas.
PNC is one of the largest regional banks in the United States, operating retail banking, corporate banking, asset management, and mortgage businesses across the Southeast, Midwest, and Mid-Atlantic regions.
The consensus Q2 2026 EPS estimate is approximately $4.45 per share. Loan demand, deposit costs, net interest margin trends, and credit quality metrics will be the primary investor focus areas.
Elevance Health (formerly Anthem) is one of the nation's largest health insurance companies, serving millions of members through commercial, Medicare, and Medicaid plans.
Analysts project Q2 2026 EPS of approximately $6.21 per share. Investors will watch the medical loss ratio — the share of premiums paid out as medical claims — and any updates to membership growth and full-year guidance. Rising care utilization has been a theme across the managed care sector.
United Airlines is one of the largest U.S. carriers by revenue, operating a global hub-and-spoke network from its primary hubs in Chicago, Houston, Newark, and San Francisco.
Analyst consensus EPS estimate is approximately $1.84 per share. Investors will focus on passenger revenue per available seat mile (PRASM), load factors, forward bookings for the summer travel season, fuel cost trends, and management's full-year guidance.
Kinder Morgan is one of North America's largest energy infrastructure companies, operating approximately 79,000 miles of pipelines and 139 terminals, primarily transporting natural gas.
Analysts expect Q2 2026 EPS of approximately $0.31 per share. Natural gas pipeline volumes and commentary on LNG-related infrastructure projects will be in focus, given growing natural gas demand from AI data centers and power generation.
Cintas Corporation (CTAS) reports Q4 fiscal 2026 results before market open, with analysts projecting EPS of approximately $1.23 per share. M&T Bank (MTB) and First Horizon (FHN) also report before the open, adding regional banking data points. J.B. Hunt Transport Services (JBHT) reports after the close, providing insight into freight volumes and intermodal shipping demand. Conagra Brands (CAG) reports before the open, with investors watching consumer food demand trends and pricing power.
Today's calendar spans multiple critical sectors simultaneously, creating an unusually broad economic picture in a single trading session.
In semiconductors and technology, ASML's results will be the most closely followed. The Dutch company is viewed as a proxy for global chip equipment spending — a market that has surged as AI infrastructure investment accelerates. Any commentary on EUV machine shipments, memory customer demand, or export control impacts on China business will move the broader semiconductor sector.
In financial services, Morgan Stanley and BlackRock complete a strong week of major bank and asset manager reports. After JPMorgan, Goldman Sachs, Citigroup, and others reported strong results earlier in the week, today's results will show whether the capital markets recovery extended through June 30.
In healthcare, J&J and Elevance represent two distinct pillars — drug development and insurance coverage. J&J's oncology pipeline and MedTech segment are key growth drivers, while Elevance faces scrutiny over healthcare utilization and cost trends that have pressured managed care margins.
United Airlines' after-close report will be the first major airline result of Q2 season. Airlines remain sensitive to fuel price swings, and with oil prices volatile amid geopolitical tensions, cost guidance will matter as much as revenue performance for investors and competing carriers alike.
ASML's report has the potential to set the tone for the semiconductor equipment sector, including Applied Materials (AMAT), Lam Research (LRCX), and KLA Corporation (KLAC). Strong results and raised guidance could support the iShares Semiconductor ETF (SOXX); cautious commentary on China export controls or order slowdowns could trigger sector-wide selling.
For financial services, the iShares U.S. Financials ETF (IYF) and SPDR S&P Bank ETF (KBE) will react to the collective picture from Morgan Stanley, BlackRock, BNY Mellon, and PNC. The sector has broadly benefited from higher-for-longer interest rates and a rebound in capital markets activity.
In healthcare, the Health Care Select Sector SPDR Fund (XLV) and iShares U.S. Healthcare Providers ETF (IHF) are sensitive to guidance changes from J&J and Elevance Health.
United Airlines' results will be watched by investors in the U.S. Global Jets ETF (JETS) and by competing carriers Delta Air Lines (DAL) and American Airlines (AAL), which report results later this week.
Earnings season continues at full pace through the rest of the week. On Thursday, July 16, Taiwan Semiconductor Manufacturing (TSM) and UnitedHealth Group (UNH) both report results, adding critical data points for the semiconductor and healthcare sectors respectively.
The next Federal Reserve meeting is scheduled for July 28–29, 2026. With the Fed funds rate held at 3.50%–3.75% since June and core PCE inflation running at 3.4% annually, corporate guidance on pricing power and cost trends from today's reporters will feed into market rate expectations.
Conference calls for before-market-open reporters typically begin between 8:00 a.m. and 10:00 a.m. Eastern Time, providing additional detail on results and forward guidance.
July 15, 2026 represents one of the busiest and most consequential days of Q2 2026 earnings season. Results from ASML, Johnson & Johnson, Morgan Stanley, BlackRock, Progressive, and a broad roster of financial, healthcare, and industrial companies will offer investors a comprehensive view of the economy heading into the second half of 2026. With the S&P 500 trading near record levels, the question is whether today's earnings can validate current valuations — or prompt investors to reassess.
Steel Dynamics (STLD), W.R. Berkley (WRB), and AMC Entertainment (AMC) report Q2 2026 earnings today. Here's what investors should know before the results.
July 20, 2026
This week's earnings calendar features Tesla, Alphabet, Intel, Texas Instruments, IBM, ServiceNow, Lockheed Martin, and American Express — a pivotal stretch of …
July 20, 2026
Fixed-rate mortgages keep your interest rate constant for the life of the loan, while adjustable-rate mortgages start with a lower rate that can change over tim…
July 20, 2026